focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

Share Price Information for Abrdn Di&g (ADIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 81.20
Bid: 80.20
Ask: 81.20
Change: 0.00 (0.00%)
Spread: 1.00 (1.247%)
Open: 81.20
High: 0.00
Low: 0.00
Prev. Close: 81.20
ADIG Live PriceLast checked at -
Aberdeen Diversified Income & Growth is an Investment Trust

To target a total portfolio return of LIBOR (London Interbank Offered Rate) plus 5.5% p.a. (net of fees) over rolling five-year periods through investments from the widest range of asset classes.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Redemption of 6.25% Bonds due 2031

10 Apr 2024 07:00

RNS Number : 9100J
abrdn Diversified Income and Growth
10 April 2024
 

abrDn diversified income and growth PLC

Legal Entity Identifier (LEI): 2138003QINEGCHYGW702

10 APRIL 2024

REDEMPTION AND CANCELLATION OF 6.25 PER CENT BONDS DUE 2031

Bond Redemption

The Board of abrdn Diversified Income and Growth plc (the "Company") hereby announces that, following the agreement of shareholders to the proposal to put the Company into managed wind-down, the Company redeemed and cancelled the remaining £16,096,000 in aggregate principal amount of its 6.25% Bonds due 2031 (ISIN XS0134340180) (the "Bonds") on 9 April 2024.

As announced on 8 March 2024, the redemption price was 114.983%. The redemption price having been calculated in accordance with the conditions, using the gross redemption yield of the United Kingdom 6% Treasury Stock due 7 December 2028.

Application has been made for the admission of £16,096,000 in principal amount of the Bonds to the Official List of the United Kingdom Listing Authority to be cancelled in accordance with the FCA's Listing Rules. Following this redemption and cancellation there remain no further Bonds outstanding and the Company has no further debt.

 

Expected circular and approvals

 

The Company has commenced the process required for Court approval for the shareholder approved reduction in the nominal value of the Company's ordinary shares from 25 pence per ordinary share to one penny per ordinary share (the "Capital Reduction") and cancellation of the entire amount standing to the credit of the Company's capital redemption reserve (the "Capital Redemption Cancellation") and share premium account to create distributable reserves which may be applied in any manner permitted by the Companies Act and/or the Company's articles of association (including for any bonus share issues and/or redemptions, tender offers, share buy backs and/or other returns of capital) excluding (in respect of the Capital Reduction and Capital Redemption Cancellation) the payment of dividends.

 

The Company also expects in the coming weeks to issue a further circular providing details of the expected initial capital return, which is proposed to be carried out by way of an issue and redemption of bonus shares to all shareholders (the "B Share Scheme"), including a summary of the UK taxation consequences for shareholders. The circular will convene a general meeting to seek the further shareholder approvals required to be granted for the implementation of the B Share Scheme. Subject to these further shareholder approvals being granted and the required Court approvals being received, it is expected that the initial return of capital will be implemented around the end of June 2024.

 

 

Contact details

For further information please contact:

abrdn Holdings Limited, Secretaries

Email: cef.cosec@abrdn.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSMFIUELSESL
Date   Source Headline
24th Jan 202412:36 pmRNSNet Asset Value(s)
23rd Jan 202412:15 pmRNSNet Asset Value(s)
22nd Jan 20242:02 pmRNSGearing disclosure
22nd Jan 202411:51 amRNSNet Asset Value(s)
19th Jan 202411:22 amRNSNet Asset Value(s)
18th Jan 202411:30 amRNSDoc re. Annual Report
18th Jan 202410:58 amRNSNet Asset Value(s)
17th Jan 202411:59 amRNSNet Asset Value(s)
16th Jan 202411:41 amRNSNet Asset Value(s)
15th Jan 20242:12 pmRNSPortfolio disclosure
15th Jan 202412:07 pmRNSGearing disclosure
15th Jan 202411:20 amRNSNet Asset Value(s)
12th Jan 202412:12 pmRNSNet Asset Value(s)
11th Jan 202412:48 pmRNSNet Asset Value(s)
10th Jan 202411:51 amRNSNet Asset Value(s)
10th Jan 20247:00 amRNSAnnual Financial Report
9th Jan 202412:21 pmRNSNet Asset Value(s)
8th Jan 20241:41 pmRNSGearing disclosure
8th Jan 202411:52 amRNSNet Asset Value(s)
5th Jan 20242:49 pmRNSMonth End Net Asset Value(s)
5th Jan 202412:28 pmRNSNet Asset Value(s)
4th Jan 202412:42 pmRNSNet Asset Value(s)
4th Jan 202410:52 amRNSReplacement - Quarterly disclosure
3rd Jan 20245:28 pmRNSQuarterly disclosure
3rd Jan 202412:29 pmRNSNet Asset Value(s)
2nd Jan 20243:03 pmRNSGearing disclosure
29th Dec 20231:12 pmRNSNet Asset Value(s)
28th Dec 202312:35 pmRNSNet Asset Value(s)
27th Dec 20231:42 pmRNSGearing disclosure
27th Dec 202312:19 pmRNSNet Asset Value(s)
22nd Dec 20231:13 pmRNSNet Asset Value(s)
21st Dec 202312:59 pmRNSNet Asset Value(s)
20th Dec 202312:03 pmRNSNet Asset Value(s)
19th Dec 202312:08 pmRNSNet Asset Value(s)
18th Dec 20234:07 pmRNSHolding(s) in Company
18th Dec 20233:05 pmRNSGearing disclosure
18th Dec 202312:53 pmRNSNet Asset Value(s)
15th Dec 202312:59 pmRNSNet Asset Value(s)
14th Dec 202312:14 pmRNSNet Asset Value(s)
14th Dec 202311:41 amRNSPortfolio disclosure
14th Dec 20237:00 amRNSProposals for Managed Wind-Down of the Company
13th Dec 202312:13 pmRNSNet Asset Value(s)
12th Dec 202312:27 pmRNSNet Asset Value(s)
11th Dec 20234:40 pmRNSGearing disclosure
11th Dec 20231:45 pmRNSNet Asset Value(s)
8th Dec 202312:18 pmRNSNet Asset Value(s)
7th Dec 20231:07 pmRNSNet Asset Value(s)
6th Dec 20232:45 pmRNSMonth End Net Asset Value(s)
6th Dec 202312:13 pmRNSNet Asset Value(s)
6th Dec 202310:05 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.